Get startedLog in
    Picture of Madrigal Pharmaceuticals logo

    MDGL — Madrigal Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapMomentum Trap
    All News

    Brief: Madrigal Expands Its Mash Pipeline With Exclusive Global Licensing Agreement For Six Preclinical Sirna Programs

    Picture of Madrigal Pharmaceuticals logoMadrigal Pharmaceuticals
    11/02/2026 11:02
    Feb 11 (Reuters) - Madrigal Pharmaceuticals Inc MDGL.O:

MADRIGAL EXPANDS ITS MASH PIPELINE WITH EXCLUSIVE GLOBAL LICENSING AGREEMENT FOR SIX PRECLINICAL SIRNA PROGRAMS

MADRIGAL PHARMACEUTICALS INC - ANNOUNCES EXCLUSIVE GLOBAL LICENSE AGREEMENT WITH SUZHOU RIBO

MADRIGAL PHARMACEUTICALS INC - RIBO TO RECEIVE $60 MILLION UPFRONT, POTENTIAL $4.4 BILLION IN PAYMENTS

Source text: ID:nGNX44BPrz

Further company coverage: MDGL.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Madrigal Pharmaceuticals

    See all news